APO Research
Talk to an analyst

APO RESEARCH · REPORT

Barbiturate Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Barbiturate Drugs Industry Growth and Trends Forecast to 2032

20 December 2025107 pages

Choose your research edition.

Industry ResearchBarbiturate Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Barbiturate Drugs Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Barbiturate Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Barbiturate Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Barbiturate Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Barbiturate Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Barbiturate Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Barbiturate Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Barbiturate Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Barbiturate Drugs include Teva Pharmaceutical, Sanofi, Merck, Mylan, Eli Lilly, Pfizer, Sumitomo Dainippon Pharma, Oak Pharmaceuticals and Meda pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Barbiturate Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Barbiturate Drugs market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Barbiturate Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Barbiturate Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Barbiturate Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Barbiturate Drugs Market by Company

Teva Pharmaceutical

Sanofi

Merck

Mylan

Eli Lilly

Pfizer

Sumitomo Dainippon Pharma

Oak Pharmaceuticals

Meda pharmaceuticals

Bausch Health

Barbiturate Drugs Segment by Type

Combination Drugs

Long-Acting Barbiturate

Short-Acting Barbiturate

Ultra-Short Acting Barbiturate

Barbiturate Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Barbiturate Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Barbiturate Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Barbiturate Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Barbiturate Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Barbiturate Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Barbiturate Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Combination Drugs Table 2. Major Company of Long-Acting Barbiturate Table 3. Major Company of Short-Acting Barbiturate Table 4. Major Company of Ultra-Short Acting Barbiturate Table 5. Global Barbiturate Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Barbiturate Drugs Sales by Type (2021-2026) & (Tons) Table 7. Global Barbiturate Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Barbiturate Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Barbiturate Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Barbiturate Drugs Price by Type (2021-2026) & (US$/Ton) Table 11. Global Barbiturate Drugs Sales by Type (2027-2032) & (Tons) Table 12. Global Barbiturate Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Barbiturate Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Barbiturate Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Barbiturate Drugs Price by Type (2027-2032) & (US$/Ton) Table 16. North America Barbiturate Drugs Sales by Type (2021-2026) & (Tons) Table 17. North America Barbiturate Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Barbiturate Drugs Sales by Type (2021-2026) & (Tons) Table 19. Europe Barbiturate Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Barbiturate Drugs Sales by Type (2021-2026) & (Tons) Table 21. Asia-Pacific Barbiturate Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Barbiturate Drugs Sales by Type (2021-2026) & (Tons) Table 23. Latin America Barbiturate Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Barbiturate Drugs Sales by Type (2021-2026) & (Tons) Table 25. Middle East and Africa Barbiturate Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Barbiturate Drugs Industry Trends Table 27. Barbiturate Drugs Industry Drivers Table 28. Barbiturate Drugs Industry Opportunities and Challenges Table 29. Barbiturate Drugs Industry Restraints Table 30. Global Barbiturate Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Barbiturate Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Barbiturate Drugs Sales by Company (2021-2026) & (Tons) Table 33. Global Barbiturate Drugs Sales Share by Company (2021-2026) Table 34. Global Barbiturate Drugs Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global Barbiturate Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Barbiturate Drugs Major Company Production Sites and Headquarters Table 37. Global Barbiturate Drugs Company, Product Type & Application Table 38. Global Barbiturate Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Barbiturate Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Barbiturate Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Barbiturate Drugs Sales by Region (2021-2026) & (Tons) Table 43. Global Barbiturate Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Barbiturate Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Barbiturate Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Barbiturate Drugs Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global Barbiturate Drugs Sales by Region (2027-2032) & (Tons) Table 48. Global Barbiturate Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Barbiturate Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Barbiturate Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Barbiturate Drugs Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global Barbiturate Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Barbiturate Drugs Sales by Application (2021-2026) & (Tons) Table 54. Global Barbiturate Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Barbiturate Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Barbiturate Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Barbiturate Drugs Price by Application (2021-2026) & (US$/Ton) Table 58. Global Barbiturate Drugs Sales by Application (2027-2032) & (Tons) Table 59. Global Barbiturate Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Barbiturate Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Barbiturate Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Barbiturate Drugs Price by Application (2027-2032) & (US$/Ton) Table 63. North America Barbiturate Drugs Sales by Application (2021-2026) & (Tons) Table 64. North America Barbiturate Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Barbiturate Drugs Sales by Application (2021-2026) & (Tons) Table 66. Europe Barbiturate Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Barbiturate Drugs Sales by Application (2021-2026) & (Tons) Table 68. Asia-Pacific Barbiturate Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Barbiturate Drugs Sales by Application (2021-2026) & (Tons) Table 70. Latin America Barbiturate Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Barbiturate Drugs Sales by Application (2021-2026) & (Tons) Table 72. Middle East and Africa Barbiturate Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Pharmaceutical Company Information Table 74. Teva Pharmaceutical Business Overview Table 75. Teva Pharmaceutical Barbiturate Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Barbiturate Drugs Product Portfolio Table 77. Teva Pharmaceutical Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Barbiturate Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Sanofi Barbiturate Drugs Product Portfolio Table 82. Sanofi Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Barbiturate Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Merck Barbiturate Drugs Product Portfolio Table 87. Merck Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Barbiturate Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Mylan Barbiturate Drugs Product Portfolio Table 92. Mylan Recent Development Table 93. Eli Lilly Company Information Table 94. Eli Lilly Business Overview Table 95. Eli Lilly Barbiturate Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Eli Lilly Barbiturate Drugs Product Portfolio Table 97. Eli Lilly Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Barbiturate Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Pfizer Barbiturate Drugs Product Portfolio Table 102. Pfizer Recent Development Table 103. Sumitomo Dainippon Pharma Company Information Table 104. Sumitomo Dainippon Pharma Business Overview Table 105. Sumitomo Dainippon Pharma Barbiturate Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Sumitomo Dainippon Pharma Barbiturate Drugs Product Portfolio Table 107. Sumitomo Dainippon Pharma Recent Development Table 108. Oak Pharmaceuticals Company Information Table 109. Oak Pharmaceuticals Business Overview Table 110. Oak Pharmaceuticals Barbiturate Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Oak Pharmaceuticals Barbiturate Drugs Product Portfolio Table 112. Oak Pharmaceuticals Recent Development Table 113. Meda pharmaceuticals Company Information Table 114. Meda pharmaceuticals Business Overview Table 115. Meda pharmaceuticals Barbiturate Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Meda pharmaceuticals Barbiturate Drugs Product Portfolio Table 117. Meda pharmaceuticals Recent Development Table 118. Bausch Health Company Information Table 119. Bausch Health Business Overview Table 120. Bausch Health Barbiturate Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Bausch Health Barbiturate Drugs Product Portfolio Table 122. Bausch Health Recent Development Table 123. North America Barbiturate Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 124. North America Barbiturate Drugs Sales by Country (2021-2026) & (Tons) Table 125. North America Barbiturate Drugs Sales Market Share by Country (2021-2026) Table 126. North America Barbiturate Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 127. North America Barbiturate Drugs Sales Market Share Forecast by Country (2027-2032) Table 128. North America Barbiturate Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Barbiturate Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Barbiturate Drugs Market Share by Country (2021-2026) Table 131. North America Barbiturate Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Barbiturate Drugs Market Share Forecast by Country (2027-2032) Table 133. Europe Barbiturate Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 134. Europe Barbiturate Drugs Sales by Country (2021-2026) & (Tons) Table 135. Europe Barbiturate Drugs Sales Market Share by Country (2021-2026) Table 136. Europe Barbiturate Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 137. Europe Barbiturate Drugs Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Barbiturate Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Barbiturate Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Barbiturate Drugs Market Share by Country (2021-2026) Table 141. Europe Barbiturate Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Barbiturate Drugs Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Barbiturate Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Barbiturate Drugs Sales by Country (2021-2026) & (Tons) Table 145. Asia-Pacific Barbiturate Drugs Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Barbiturate Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 147. Asia-Pacific Barbiturate Drugs Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Barbiturate Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Barbiturate Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Barbiturate Drugs Market Share by Country (2021-2026) Table 151. Asia-Pacific Barbiturate Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Barbiturate Drugs Market Share Forecast by Country (2027-2032) Table 153. Latin America Barbiturate Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 154. Latin America Barbiturate Drugs Sales by Country (2021-2026) & (Tons) Table 155. Latin America Barbiturate Drugs Sales Market Share by Country (2021-2026) Table 156. Latin America Barbiturate Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 157. Latin America Barbiturate Drugs Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Barbiturate Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Barbiturate Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Barbiturate Drugs Market Share by Country (2021-2026) Table 161. Latin America Barbiturate Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Barbiturate Drugs Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Barbiturate Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Barbiturate Drugs Sales by Country (2021-2026) & (Tons) Table 165. Middle East and Africa Barbiturate Drugs Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Barbiturate Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 167. Middle East and Africa Barbiturate Drugs Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Barbiturate Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Barbiturate Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Barbiturate Drugs Market Share by Country (2021-2026) Table 171. Middle East and Africa Barbiturate Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Barbiturate Drugs Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Barbiturate Drugs Distributors List Table 176. Barbiturate Drugs Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Barbiturate Drugs Image Figure 2. Global Barbiturate Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Barbiturate Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Barbiturate Drugs Sales (2021-2032) & (Tons) Figure 5. Combination Drugs Image Figure 6. Global Combination Drugs Sales YoY Growth (2021-2032) & (Tons) Figure 7. Long-Acting Barbiturate Image Figure 8. Global Long-Acting Barbiturate Sales YoY Growth (2021-2032) & (Tons) Figure 9. Short-Acting Barbiturate Image Figure 10. Global Short-Acting Barbiturate Sales YoY Growth (2021-2032) & (Tons) Figure 11. Ultra-Short Acting Barbiturate Image Figure 12. Global Ultra-Short Acting Barbiturate Sales YoY Growth (2021-2032) & (Tons) Figure 13. Global Barbiturate Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Barbiturate Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Barbiturate Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Barbiturate Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Barbiturate Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Barbiturate Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Barbiturate Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Barbiturate Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Barbiturate Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Barbiturate Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Barbiturate Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Barbiturate Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Barbiturate Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (Tons) Figure 29. Online Pharmacies Image Figure 30. Global Online Pharmacies Sales YoY Growth (2021-2032) & (Tons) Figure 31. Hospital Pharmacies Image Figure 32. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (Tons) Figure 33. Global Barbiturate Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Barbiturate Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Barbiturate Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Barbiturate Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Barbiturate Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Barbiturate Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Barbiturate Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Barbiturate Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Barbiturate Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Barbiturate Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Barbiturate Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Barbiturate Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Barbiturate Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. North America Barbiturate Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Barbiturate Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Barbiturate Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Barbiturate Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Europe Barbiturate Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Barbiturate Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Barbiturate Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Barbiturate Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Asia-Pacific Barbiturate Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Barbiturate Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Barbiturate Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Barbiturate Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Latin America Barbiturate Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Barbiturate Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Barbiturate Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Barbiturate Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 62. Middle East and Africa Barbiturate Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Barbiturate Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Barbiturate Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Barbiturate Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Barbiturate Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Combination Drugs
  • Long-Acting Barbiturate
  • Short-Acting Barbiturate
  • Ultra-Short Acting Barbiturate
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Merck
  • Mylan
  • Eli Lilly
  • Pfizer
  • Sumitomo Dainippon Pharma
  • Oak Pharmaceuticals
  • Meda pharmaceuticals
  • Bausch Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Barbiturate Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Barbiturate Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Barbiturate Drugs Market by Type
  6. 1.3.1 Combination Drugs
  7. 1.3.2 Long-Acting Barbiturate
  8. 1.3.3 Short-Acting Barbiturate
  9. 1.3.4 Ultra-Short Acting Barbiturate
  10. 1.4 Global Barbiturate Drugs Market Size by Type
  11. 1.4.1 Global Barbiturate Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Barbiturate Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Barbiturate Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Barbiturate Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Barbiturate Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Barbiturate Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Barbiturate Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Barbiturate Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Barbiturate Drugs Industry Trends
  2. 2.2 Barbiturate Drugs Industry Drivers
  3. 2.3 Barbiturate Drugs Industry Opportunities and Challenges
  4. 2.4 Barbiturate Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Barbiturate Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Barbiturate Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Barbiturate Drugs Price (2021-2026)
  4. 3.4 Global Barbiturate Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Barbiturate Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Barbiturate Drugs Company, Product Type & Application
  7. 3.7 Global Barbiturate Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Barbiturate Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Barbiturate Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Barbiturate Drugs Tier 1, Tier 2, and Tier 3
4 Barbiturate Drugs Regional Status and Outlook
  1. 4.1 Global Barbiturate Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Barbiturate Drugs Historic Market Size by Region
  3. 4.2.1 Global Barbiturate Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Barbiturate Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Barbiturate Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Barbiturate Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Barbiturate Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Barbiturate Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Barbiturate Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Barbiturate Drugs by Application
  1. 5.1 Barbiturate Drugs Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Barbiturate Drugs Market Size by Application
  6. 5.2.1 Global Barbiturate Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Barbiturate Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Barbiturate Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Barbiturate Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Barbiturate Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Barbiturate Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Barbiturate Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Barbiturate Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Barbiturate Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Barbiturate Drugs Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Barbiturate Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Barbiturate Drugs Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Barbiturate Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Barbiturate Drugs Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Barbiturate Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Barbiturate Drugs Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Barbiturate Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly Barbiturate Drugs Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Barbiturate Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Barbiturate Drugs Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Sumitomo Dainippon Pharma
  38. 6.7.1 Sumitomo Dainippon Pharma Company Information
  39. 6.7.2 Sumitomo Dainippon Pharma Business Overview
  40. 6.7.3 Sumitomo Dainippon Pharma Barbiturate Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sumitomo Dainippon Pharma Barbiturate Drugs Product Portfolio
  42. 6.7.5 Sumitomo Dainippon Pharma Recent Developments
  43. 6.8 Oak Pharmaceuticals
  44. 6.8.1 Oak Pharmaceuticals Company Information
  45. 6.8.2 Oak Pharmaceuticals Business Overview
  46. 6.8.3 Oak Pharmaceuticals Barbiturate Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Oak Pharmaceuticals Barbiturate Drugs Product Portfolio
  48. 6.8.5 Oak Pharmaceuticals Recent Developments
  49. 6.9 Meda pharmaceuticals
  50. 6.9.1 Meda pharmaceuticals Company Information
  51. 6.9.2 Meda pharmaceuticals Business Overview
  52. 6.9.3 Meda pharmaceuticals Barbiturate Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Meda pharmaceuticals Barbiturate Drugs Product Portfolio
  54. 6.9.5 Meda pharmaceuticals Recent Developments
  55. 6.10 Bausch Health
  56. 6.10.1 Bausch Health Company Information
  57. 6.10.2 Bausch Health Business Overview
  58. 6.10.3 Bausch Health Barbiturate Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bausch Health Barbiturate Drugs Product Portfolio
  60. 6.10.5 Bausch Health Recent Developments
7 North America by Country
  1. 7.1 North America Barbiturate Drugs Sales by Country
  2. 7.1.1 North America Barbiturate Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Barbiturate Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Barbiturate Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Barbiturate Drugs Market Size by Country
  6. 7.2.1 North America Barbiturate Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Barbiturate Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Barbiturate Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Barbiturate Drugs Sales by Country
  2. 8.1.1 Europe Barbiturate Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Barbiturate Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Barbiturate Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Barbiturate Drugs Market Size by Country
  6. 8.2.1 Europe Barbiturate Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Barbiturate Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Barbiturate Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Barbiturate Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Barbiturate Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Barbiturate Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Barbiturate Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Barbiturate Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Barbiturate Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Barbiturate Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Barbiturate Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Barbiturate Drugs Sales by Country
  2. 10.1.1 South America Barbiturate Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Barbiturate Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Barbiturate Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Barbiturate Drugs Market Size by Country
  6. 10.2.1 South America Barbiturate Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Barbiturate Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Barbiturate Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Barbiturate Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Barbiturate Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Barbiturate Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Barbiturate Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Barbiturate Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Barbiturate Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Barbiturate Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Barbiturate Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Barbiturate Drugs Value Chain Analysis
  2. 12.1.1 Barbiturate Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Barbiturate Drugs Production Mode & Process
  7. 12.2 Barbiturate Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Barbiturate Drugs Distributors
  10. 12.2.3 Barbiturate Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst